Pablo G. Legorreta - May 16, 2023 Form 4 Insider Report for Royalty Pharma plc (RPRX)

Role
CEO, Chairman of the Board, Director, 10%+ Owner
Signature
/s/ Sean Weisberg, as Attorney-in-Fact for Pablo G. Legorreta
Stock symbol
RPRX
Transactions as of
May 16, 2023
Transactions value $
$7,676,824
Form type
4
Date filed
5/17/2023, 06:41 PM
Previous filing
May 15, 2023
Next filing
May 24, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RPRX Class A ordinary shares Purchase $5.38M +160K $33.57 160K May 16, 2023 By Legorreta 2023 SR Trust F1, F2
transaction RPRX Class A ordinary shares Purchase $2.29M +69.6K +43.4% $32.94 230K May 17, 2023 By Legorreta 2023 SR Trust F1, F3
holding RPRX Class A ordinary shares 63.8K May 16, 2023 Direct
holding RPRX Class A ordinary shares 460K May 16, 2023 By Legorreta Investments LLC
holding RPRX Class A ordinary shares 1.28M May 16, 2023 By GST-Exempt Legorreta 2012 Family Trust
holding RPRX Class A ordinary shares 41.3K May 16, 2023 By GST-Exempt Legorreta 2020 Family Trust
holding RPRX Class A ordinary shares 10K May 16, 2023 By Child
holding RPRX Class A ordinary shares 10K May 16, 2023 By Child
holding RPRX Class A ordinary shares 123K May 16, 2023 By IRRA
holding RPRX Class A ordinary shares 119K May 16, 2023 By SEP/IRA
holding RPRX Class A ordinary shares 1.04M May 16, 2023 By Legorreta Children 2002 Trust
holding RPRX Class A ordinary shares 6.93K May 16, 2023 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares acquired by the reporting person in open market transactions as part of the reporting person's previously disclosed intention to purchase up to $50 million of the issuer's Class A ordinary shares, as announced in the issuer's press release on March 27, 2023 regarding the issuer's $1.0 billion share repurchase program.
F2 The price reported in Column 4 is a weighted average price. The reported securities were purchased in multiple transactions at prices ranging from $33.48 to $33.76. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range.
F3 The price reported in Column 4 is a weighted average price. The reported securities were purchased in multiple transactions at prices ranging from $32.70 to $33.28. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range.